A protein-stabilizing technology for enhanced antibody stability and antibody-binding profiles in a microchip array

Biotechnology Journal

Volumn 7, Issue 8, 2012, Pages 1002-1007

  Scholz, Martin ^a   Lüking, Angelika ^b  

^a LEUKOCARE AG   (Germany)

^b PROTAGEN AG   (Germany)

Author keywords

Antibody; Diagnostics; Microarray; Proteins; Stability

Indexed keywords

ANTIBODY-BINDING; BINDING SPECIFICITIES; BINDING STRENGTH; DOWNSTREAM-PROCESSING; MICROCHIP ARRAY; NOVEL PROTEINS; PROTEIN MICROARRAY; QUANTITATIVE BINDING; STABILIZING EFFECTS; THERAPEUTIC ANTIBODIES;

CONVERGENCE OF NUMERICAL METHODS; MICROARRAYS; PLASMA DIAGNOSTICS; PROTEINS; RECOMBINANT PROTEINS;

ANTIBODIES;

ADALIMUMAB; RECOMBINANT ANTIGEN;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; DRUG BINDING; DRUG STABILITY; DRUG STORAGE; MICROCHIP ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEIN STABILITY; QUANTITATIVE ANALYSIS;

ANTIBODIES; BIOTECHNOLOGY; HUMANS; MICROARRAY ANALYSIS; PROTEIN BINDING; PROTEIN STABILITY; PROTEINS;

EID: 84864806597     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201100494     Document Type: Article

References (14)

1. Gianfreda, L., Scarfi, M. R., Enzyme stabilization: State of the art. Mol. Cell. Biochem. 1991, 100, 97-128.
2. Stadtman, E. R., Levine, R. L., Protein oxidation. Ann. N. Y. Acad. Sci. 2000, 899, 191-208.
3. Kapoor, S., Priyadarsini, K. I., Protection of radiation-induced protein damage by curcumin. Biophys. Chem. 2001, 92, 119-126.
4. Scholz, M., Altenhofen, W., Stabilising biologics for vaccine production. SPS. Manuf. Chem. 2011, 9, 32-34.
5. Han, Y., Jin, B. S., Lee, S. B., Sohn, Y. et al., Effects of sugar additives on protein stability of recombinant human serum albumin during lyophilization and storage. Arch. Pharmacal Res. 2007, 30, 1124-1131.
6. Feyen, O., Lueking, A., Kowald, A., Stephan, C. et al., Off-target activity of TNF-alpha inhibitors characterized by protein biochips. Anal. Bioanal. Chem. 2008, 391, 1713-1720.
7. Lueking, A., Beator, J., Patz, E., Müllner, S. et al., Determination and validation of off-target activities of anti-CD44 variant 6 antibodies using protein biochips and tissue microarrays. BioTechniques 2008, 45, Pi-v.
8. Lueking, A., Huber, O., Wirths, C., Schulte, K. et al., Profiling of alopecia areata autoantigens based on protein microarray technology. Mol. Cell. Proteomics 2005, 4, 1382-1390.
9. Schlehuber, S., Skerra, A., Anticalins as an alternative to antibody technology. Expert Opin. Biol. Ther. 2005, 5, 1453-1462.
10. Vaneycken, I., D'huyvetter, M., Hernot, S., De Vos, J. et al., Immuno-imaging using nanobodies. Curr. Opin. Biotechnol. 2011, 22, 877-881.
11. Lipovsek, D., Adnectins: Engineered target-binding protein therapeutics. Protein Eng., Des. Sel. 2011, 24, 3-9.
12. Dean, K. E., Hikaka, J., Huakau, J. T., Walmsley, R. S., Infliximab or cyclosporine for acute severe ulcerative colitis: A retrospective analysis. J. Gastroenterol. Hepatol. 2012, 27, 487-492.
13. Kayser, V., Chennamsetty, N., Voynov, V., Forrer, K., Helk, B., Trout, B. L., Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies. Biotechnol. J. 2011, 6, 38-44.
14. Arakawa, T., Prestrelski, S. J., Kenney, W. C., Carpenter, J. F., Factors affecting short-term and long-term stabilities of proteins. Adv. Drug Delivery Rev. 2001, 46, 307-326.